Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Fisherman Attacked by Great White Shark Says ‘My Left Foot Was in His Mouth’ - 2Scientists Just Discovered Japan’s First New Bird Species in Over 40 Years
- 3New electric car registrations rise sharply in Germany in March
- 4Find the Marvels of the World with These Travels
- 5Pain at the pump for Hampton Roads residents
- Strengthening through Wellness: Individual Preparation Achievement
- My Enterprising Excursion: Building a Startup
- New COVID-19 variant 'Cicada' is spreading. What to know about BA.3.2.
- James Webb Space Telescope watches 'Jekyll and Hyde' galaxy shapeshift into a cosmic monster
- St George Mining hits record 178m high-grade intercept at Araxá, reinforcing global scale
- Louisiana seeks California doctor’s extradition, testing the limits of shield laws
- Huge rotating structure of galaxies and dark matter is detected
- Dancing through the crackdown: The satirical song soundtracking post-Khamenei Iran
- Rescuers again fail to free whale stranded on Germany's Baltic coast
